This week on "The Top Line," we explore biopharma layoffs in the first quarter of 2024.
Using data from Fierce Biotech's layoff tracker, Gabrielle Masson and Max Bayer analyze the trends of layoffs in the first quarter of 2024, comparing them to previous years. With a notable number of layoff rounds marking the start of the year, they examine the factors behind this ongoing challenge while also highlighting positive industry developments.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.
December 16, 2022
December 9, 2022
December 2, 2022
[Sponsored] Slope’s Hope Meely on the importance of a fully enabled clinical supply platform
November 18, 2022
November 11, 2022
November 4, 2022
October 28, 2022
October 19, 2022
October 14, 2022
October 6, 2022
September 30, 2022
September 23, 2022
September 16, 2022
September 9, 2022
September 2, 2022
August 26, 2022
August 19, 2022
August 12, 2022
August 5, 2022
Create your
podcast in
minutes
It is Free
Pharmacy Podcast Network
Børsen Morgenbriefing
Sarah Westall - Business Game Changers
Startitup podcasty
Wall Street Breakfast